Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-21

FDA Approved: NALOXONE HYDROCHLORIDE — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Meitheal Pharmaceuticals' naloxone hydrochloride as a generic drug based on an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

ORIG AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)